Uncertainty about the Efficacy of Remdesivir on COVID-19
- Affiliations
-
- 1Division of Infectious Diseases, Department of Internal Medicine, Bucheon St. Mary's Hospital, Bucheon, Korea
- 2Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
- KMID: 2502926
- DOI: http://doi.org/10.3346/jkms.2020.35.e221
Cited by 2 articles
-
Convalescent Plasma Therapy in Coronavirus Disease 2019: a Case Report and Suggestions to Overcome Obstacles
Jae Hyoung Im, Chung Hyun Nahm, Ji Hyeon Baek, Hea Yoon Kwon, Jin-Soo Lee
J Korean Med Sci. 2020;35(26):e239. doi: 10.3346/jkms.2020.35.e239.Clinical and Virologic Effectiveness of Remdesivir Treatment for Severe Coronavirus Disease 2019 (COVID-19) in Korea: a Nationwide Multicenter Retrospective Cohort Study
Eun-Jeong Joo, Jae-Hoon Ko, Seong Eun Kim, Seung-Ji Kang, Ji Hyeon Baek, Eun Young Heo, Hye Jin Shi, Joong Sik Eom, Pyoeng Gyun Choe, Seongman Bae, Sang Hyun Ra, Da Young Kim, Baek-Nam Kim, Yu Min Kang, Ji Yeon Kim, Jin-Won Chung, Hyun-Ha Chang, Sohyun Bae, Shinhyea Cheon, Yoonseon Park, Heun Choi, Eunjung Lee, Bo young Lee, Jung Wan Park, Yujin Sohn, Jung Yeon Heo, Sung-Han Kim, Kyong Ran Peck
J Korean Med Sci. 2021;36(11):e83. doi: 10.3346/jkms.2021.36.e83.
Reference
-
1. Scavone C, Brusco S, Bertini M, Sportiello L, Rafaniello C, Zoccoli A, et al. Current pharmacological treatments for COVID-19: What's next? Br J Pharmacol. Forthcoming. 2020; DOI: 10.1111/bph.15072.
Article2. Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020; 395(10236):1569–1578. PMID: 32423584.3. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of Covid-19 - preliminary report. N Engl J Med. Forthcoming. 2020; DOI: 10.1056/NEJMoa2007764.
Article
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Systematic Review for Remdesivir Use in Pediatric Patients under 3.5 kg with COVID-19
- A Case Report for Severe COVID-19 in a 9-Year-Old Child Treated with Remdesivir and Dexamethasone
- Development of Theory of Uncertainty on COVID-19: Theory Derivation Based on Uncertainty in Illness Theory
- Effectiveness of Regdanvimab and Remdesivir in Patients with COVID-19 at a Single Hospital
- Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia
